Metformin Potentiates the Effects of Anlotinib in NSCLC via AMPK/mTOR and ROS-Mediated Signaling Pathways

MLA

Zhongling Zhu, et al. “Metformin Potentiates the Effects of Anlotinib in NSCLC via AMPK/MTOR and ROS-Mediated Signaling Pathways.” Frontiers in Pharmacology, vol. 12, Aug. 2021. EBSCOhost, https://doi.org/10.3389/fphar.2021.712181.

APA

Zhongling Zhu, Teng Jiang, Huirong Suo, Shan Xu, Cai Zhang, Guoguang Ying, & Zhao Yan. (2021). Metformin Potentiates the Effects of Anlotinib in NSCLC via AMPK/mTOR and ROS-Mediated Signaling Pathways. Frontiers in Pharmacology, 12. https://doi.org/10.3389/fphar.2021.712181

Chicago

Zhongling Zhu, Teng Jiang, Huirong Suo, Shan Xu, Cai Zhang, Guoguang Ying, and Zhao Yan. 2021. “Metformin Potentiates the Effects of Anlotinib in NSCLC via AMPK/MTOR and ROS-Mediated Signaling Pathways.” Frontiers in Pharmacology 12 (August). doi:10.3389/fphar.2021.712181.